Anebulo Pharmaceuticals(ANEB) - 2024 Q4 - Annual Results

Exhibit 99.1 Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates AUSTIN, Texas (September 25, 2024) – Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or "Anebulo"), today announced financial results for the three and twelve months ended June 30, 2024, and recent updates. Fourth Quarter Fiscal Year 2024 and Subse ...